A. Schumacher

Chlamydia pneumoniae Serology: Importance of Methodology in Patients with Coronary Heart Disease and Healthy Individuals

I. Holme, H. Arnesen, I. Seljeflot, 2001, Journal of Clinical Microbiology.

A rodent model of alcoholic heart muscle disease and its evaluation by echocardiography.

M. Piano, T. Bieniarz, Shann D. Kim, 2001, Alcoholism, clinical and experimental research.

Positive Chlamydia pneumoniae serology is associated with elevated levels of tumor necrosis factor alpha in patients with coronary heart disease.

H. Arnesen, I. Seljeflot, J. Otterstad, 2002, Atherosclerosis.

Increased levels of markers of vascular inflammation in patients with coronary heart disease

H. Arnesen, I. Seljeflot, J. Otterstad, 2002, Scandinavian journal of clinical and laboratory investigation.

Does infection with Chlamydia pneumoniae and/or Helicobacter pylori increase the expression of endothelial cell adhesion molecules in humans?

H. Arnesen, I. Seljeflot, J. Otterstad, 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Chlamydia LPS and MOMP seropositivity are associated with different cytokine profiles in patients with coronary heart disease

H. Arnesen, I. Seljeflot, J. Otterstad, 2005, European journal of clinical investigation.

Elevated Serum Cyclophilin Levels in Patients with Severe Sepsis

H. Bang, K. Brune, H. Geiger, 1997, Journal of Clinical Immunology.

Increased levels of endothelial haemostatic markers in patients with coronary heart disease.

H. Arnesen, I. Seljeflot, J. Otterstad, 2002, Thrombosis research.

Physical performance is associated with markers of vascular inflammation in patients with coronary heart disease

H. Arnesen, I. Seljeflot, K. Peersen, 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Increased levels of soluble markers of endothelial dysfunction in patients with atherosclerotic heart disease

H. Arnesen, I. Seljeflot, A. Schumacher, 2000 .

ECHO parameters of diastolic dysfunction

A. Schumacher, DF Larson, Ev Khojeini, 2008, Perfusion.

Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controls

K. Birkeland, L. Sandvik, J. Bruun, 2006, Scandinavian journal of infectious diseases.